Latest News about BLUE
Recent news which mentions BLUE
28 Stocks Moving in Friday's Pre-Market Session
November 05, 2021
From Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
From Motley Fool
Bluebird Bio To Withdraw Marketing Of Skysona Gene Therapy In Europe
October 21, 2021
Tickers
BLUE
From Benzinga
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
October 20, 2021
From Motley Fool
From InvestorPlace
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
Bluebird Bio Files US Application For β-thalassemia Gene Therapy
September 22, 2021
Tickers
BLUE
From Benzinga
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
From InvestorPlace
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Latest Barron's Picks And Pans Include General Electric, Netflix, Reddit And More
September 04, 2021
From Benzinga
Earnings Roundup: Disney, Airbnb, eBay, and More
August 24, 2021
From Motley Fool
2 Soaring Biotech Stocks With More Fuel in the Tank
August 23, 2021
From Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
3 Beaten-Down Biotech Stocks to Buy Right Now
August 18, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
68 Biggest Movers From Yesterday
August 10, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 09, 2021
From Benzinga
Bluebird Bio's Shares Drop To 52-Week Low After Another Gene Therapy Trial Placed On FDA Hold
August 09, 2021
Tickers
BLUE
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.